Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07421596 · ClinicalTrials.gov registry record · NA

An 8-Week Study Evaluating Gut and Digestive Health After Use of a Dietary Supplement System

A NA study of Gut Health and Digestive Health, sponsored by SF Research Institute.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT07421596 is a NA study of Gut Health and Digestive Health that is actively recruiting participants, run by SF Research Institute. The registered enrollment target is 50 participants, below the 57-participant average among 9 other Gut Health trials with a reported enrollment target (12% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07421596, a NA study of Gut Health and Digestive Health, is actively recruiting participants, sponsored by SF Research Institute.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This clinical research study is being conducted to evaluate gut and digestive health before and after the use of a dietary supplement system over an eight-week period. Gut and digestive health play an important role in overall health, including digestion, nutrient absorption, immune function, and metabolic balance. Changes in gut microbiota, inflammation, and intestinal barrier function may contribute to digestive symptoms such as bloating, discomfort, altered bowel habits, and reduced well-being. In this study, adult men and women with self-reported gastrointestinal symptoms will consume a dietary supplement system daily for eight weeks. The study will measure changes in gut and digestive health using objective stool-based laboratory biomarkers and validated symptom questionnaires. Stool samples will be collected at baseline and at the end of the study to evaluate markers related to microbial diversity, inflammation, immune activity, digestive function, and intestinal barrier integrity. Participants will also complete questionnaires throughout the study to assess gastrointestinal symptoms and subjective digestive health and well-being. The study will also monitor the safety and tolerability of the dietary supplement system during the study period.

Interventions

  • DIETARY_SUPPLEMENT PhytoPower 1 and PhytoPower 2

Study Locations (1)

California

  • San Francisco Research Institute - San Francisco

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2026-02-05
Est. Completion 2026-04-21
Phase NA

Sponsor

SF Research Institute

16 total trials

What the Registry Record Tells You About NCT07421596

The ClinicalTrials.gov registry entry for NCT07421596 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 57-participant average among 9 other Gut Health trials with a reported enrollment target (12% lower). The listed sponsor is SF Research Institute, which has 16 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Gut Health appearing as the primary indexed condition, and to 1 intervention - of which PhytoPower 1 and PhytoPower 2 is the first listed.

NCT07421596 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT07421596 about?

NCT07421596 is a clinical study titled "An 8-Week Study Evaluating Gut and Digestive Health After Use of a Dietary Supplement System". This clinical research study is being conducted to evaluate gut and digestive health before and after the use of a dietary supplement system over an eight-week period. Gut and digestive health play an important role in overall health, including digestion, nutrient absorption, immune function, and m...

What is the current status of trial NCT07421596?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-02-05. Estimated completion is 2026-04-21.

What conditions does trial NCT07421596 study?

This clinical trial studies the following conditions: Gut Health, Digestive Health, Gastrointestinal Symptoms.

What interventions are being tested in trial NCT07421596?

The interventions under investigation include: PhytoPower 1 and PhytoPower 2 (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT07421596?

This trial is sponsored by SF Research Institute, which has 16 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07421596 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gut Health

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.